Debra BorchardtMay 12, 2023
Missouri legalization impacted Illinois sales.
Tag: earnings
Debra BorchardtMay 12, 2023Debra BorchardtMay 11, 2023
Psychedelic drug company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the first quarter of 2023 and gave an update on recent progress across its business. Compass Pathways has no revenue at this time to report. It had a net loss of $24.2 million, or $0.57 loss per share (including non-cash share-based compensation […]
Debra BorchardtMay 10, 2023
Net income for the first quarter fell 16% from the same period a year ago.
Debra BorchardtMay 10, 2023
Despite higher prices, produce sales fall.
Debra BorchardtMay 5, 2023
StateHouse recorded a net loss of $196 million in the fourth quarter.
Debra BorchardtMay 2, 2023
Profitability is a key focus of the company's 2023 business outlook.
Debra BorchardtMay 1, 2023
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., released its financial results for the fourth quarter and year ended December 31, 2022. The company reported $1.5 million in sales for the quarter versus last year’s $339k for […]
Debra BorchardtMay 1, 2023
BZAM says it's a going concern.
Adam JacksonFebruary 2, 2023
The company reported that it is more $137 million in debt, with $15 million cash and equivalents on the books.
Adam JacksonOctober 13, 2022
Shares for The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) ticked up this morning as the company has managed to cut its losses, which had been far outpacing revenue over the past year. The company, which announced an acquisition deal with SNDL, Inc. (Nasdaq: SNDL) in August, released its third quarter financial report card for […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.